Daniel Steinberg - Michigan [Web]

Daniel Steinberg (1922–2015) was a pioneering physician-scientist at the and the University of California, San Diego (UCSD) , whose monumental work laid the foundation for our modern understanding of cholesterol and heart disease. While he is not primarily associated with the University of Michigan as a faculty member, his legacy is deeply intertwined with the broader academic and medical communities in Michigan, particularly through the implementation of the lipid-lowering protocols he championed. The Father of the LDL Oxidation Hypothesis

His work continues to influence major research institutions, including the University of Michigan Medical School , where the study of cardiovascular disease and lipid metabolism remains a primary focus of the Frankel Cardiovascular Center . Daniel Steinberg, 1922–2015 - PMC - NIH Daniel Steinberg - Michigan

Steinberg’s most significant scientific contribution was the development of the . Over three decades, he and his colleagues published over 100 manuscripts providing evidence that oxidized LDL cholesterol drives the development of atherosclerosis (the buildup of fats and cholesterol in artery walls). Daniel Steinberg, 1922–2015 - PMC - NIH Steinberg’s

Beyond laboratory work, Steinberg was a critical force in proving that lowering cholesterol actually saves lives. He served as the for the Lipid Research Clinics Coronary Primary Prevention Trial , the first major study to demonstrate that drug-induced lipid lowering could reduce heart attacks. He served as the for the Lipid Research

This was a landmark feat given the medical skepticism of the time and the difficulty of the available treatments, which Steinberg once famously described as being "more or less like eating sand" due to their poor palatability.